Cargando…

Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group

BACKGROUND: The evaluation of immune response can aid in prediction of cancer behaviour. Here, we assessed the prognostic significance of tumour-infiltrating lymphocytes (TILs) in oropharyngeal squamous cell carcinoma (OPSCC). METHODS: A total of 182 patients treated for OPSCC were included in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Almangush, Alhadi, Jouhi, Lauri, Atula, Timo, Haglund, Caj, Mäkitie, Antti A., Hagström, Jaana, Leivo, Ilmo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130301/
https://www.ncbi.nlm.nih.gov/pubmed/35043007
http://dx.doi.org/10.1038/s41416-022-01708-7
_version_ 1784712958686789632
author Almangush, Alhadi
Jouhi, Lauri
Atula, Timo
Haglund, Caj
Mäkitie, Antti A.
Hagström, Jaana
Leivo, Ilmo
author_facet Almangush, Alhadi
Jouhi, Lauri
Atula, Timo
Haglund, Caj
Mäkitie, Antti A.
Hagström, Jaana
Leivo, Ilmo
author_sort Almangush, Alhadi
collection PubMed
description BACKGROUND: The evaluation of immune response can aid in prediction of cancer behaviour. Here, we assessed the prognostic significance of tumour-infiltrating lymphocytes (TILs) in oropharyngeal squamous cell carcinoma (OPSCC). METHODS: A total of 182 patients treated for OPSCC were included in this study. Assessment of TILs was conducted on tumour sections stained with standard haematoxylin and eosin (HE) staining. We used the scoring criteria proposed by the International Immuno-Oncology Biomarker Working Group. RESULTS: The multivariable analysis showed that TILs associated with disease-specific survival with a hazard ratio (HR) of 2.13 (95% CI 1.14–3.96; P = 0.017). Similarly, TILs associated significantly with overall survival with HR of 1.87 (95% CI 1.11–3.13; P = 0.018). In a sub-analysis of HPV-positive and HPV-negative cases separately, TILs showed a significant prognostic value in both groups (P < 0.05). CONCLUSION: The evaluation of TILs as proposed by the International Immuno-Oncology Biomarker Working Group is a simple and promising method in prediction of survival of OPSCC. It is easily applicable and after further validation can be implemented in the routine pathological report as a basic immune parameter.
format Online
Article
Text
id pubmed-9130301
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91303012022-05-26 Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group Almangush, Alhadi Jouhi, Lauri Atula, Timo Haglund, Caj Mäkitie, Antti A. Hagström, Jaana Leivo, Ilmo Br J Cancer Article BACKGROUND: The evaluation of immune response can aid in prediction of cancer behaviour. Here, we assessed the prognostic significance of tumour-infiltrating lymphocytes (TILs) in oropharyngeal squamous cell carcinoma (OPSCC). METHODS: A total of 182 patients treated for OPSCC were included in this study. Assessment of TILs was conducted on tumour sections stained with standard haematoxylin and eosin (HE) staining. We used the scoring criteria proposed by the International Immuno-Oncology Biomarker Working Group. RESULTS: The multivariable analysis showed that TILs associated with disease-specific survival with a hazard ratio (HR) of 2.13 (95% CI 1.14–3.96; P = 0.017). Similarly, TILs associated significantly with overall survival with HR of 1.87 (95% CI 1.11–3.13; P = 0.018). In a sub-analysis of HPV-positive and HPV-negative cases separately, TILs showed a significant prognostic value in both groups (P < 0.05). CONCLUSION: The evaluation of TILs as proposed by the International Immuno-Oncology Biomarker Working Group is a simple and promising method in prediction of survival of OPSCC. It is easily applicable and after further validation can be implemented in the routine pathological report as a basic immune parameter. Nature Publishing Group UK 2022-01-18 2022-06-01 /pmc/articles/PMC9130301/ /pubmed/35043007 http://dx.doi.org/10.1038/s41416-022-01708-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Almangush, Alhadi
Jouhi, Lauri
Atula, Timo
Haglund, Caj
Mäkitie, Antti A.
Hagström, Jaana
Leivo, Ilmo
Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group
title Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group
title_full Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group
title_fullStr Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group
title_full_unstemmed Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group
title_short Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group
title_sort tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the international immuno-oncology biomarker working group
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130301/
https://www.ncbi.nlm.nih.gov/pubmed/35043007
http://dx.doi.org/10.1038/s41416-022-01708-7
work_keys_str_mv AT almangushalhadi tumourinfiltratinglymphocytesinoropharyngealcanceravalidationstudyaccordingtothecriteriaoftheinternationalimmunooncologybiomarkerworkinggroup
AT jouhilauri tumourinfiltratinglymphocytesinoropharyngealcanceravalidationstudyaccordingtothecriteriaoftheinternationalimmunooncologybiomarkerworkinggroup
AT atulatimo tumourinfiltratinglymphocytesinoropharyngealcanceravalidationstudyaccordingtothecriteriaoftheinternationalimmunooncologybiomarkerworkinggroup
AT haglundcaj tumourinfiltratinglymphocytesinoropharyngealcanceravalidationstudyaccordingtothecriteriaoftheinternationalimmunooncologybiomarkerworkinggroup
AT makitieanttia tumourinfiltratinglymphocytesinoropharyngealcanceravalidationstudyaccordingtothecriteriaoftheinternationalimmunooncologybiomarkerworkinggroup
AT hagstromjaana tumourinfiltratinglymphocytesinoropharyngealcanceravalidationstudyaccordingtothecriteriaoftheinternationalimmunooncologybiomarkerworkinggroup
AT leivoilmo tumourinfiltratinglymphocytesinoropharyngealcanceravalidationstudyaccordingtothecriteriaoftheinternationalimmunooncologybiomarkerworkinggroup